Potency of Fusion-Inhibitory Lipopeptides against SARS-CoV-2 Variants of Concern is a research paper published in mBio (2022). On theSindex it has a DataRank of 0.716. It has been cited 22 times, with 17 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.470
From this paper's citation signal
Citation Network Contribution
0.246
From 13 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 17 citers.
National Institutes of Health
Grant: RO1 AI160961
HHS | National Institutes of Health
Grant: RO1 AI160953
NIAID NIH HHS
Grant: R01 AI160953
NIAID NIH HHS
Grant: R01 AI160961
National Institutes of Health
Grant: 4R01AI160961-03
Engineering protease-resistant antiviral peptide inhibitors for SARS-CoV-2
National Institutes of Health
Grant: 4R01AI160953-03
Fusion inhibitors that block host-to-host transmission of SARS-CoV-2
European Commission
Grant: 871029
European Virus Archive GLOBAL
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals